title: Pharmacokinetics and Metabolism of Selective Oxoeicosanoid (OXE) Receptor Antagonists and Their Effects on 5-Oxo-6,8,11,14-eicosatetraenoic Acid (5-Oxo-ETE)-Induced Granulocyte Activation in Monkeys.
abstract: The potent eosinophil chemoattractant 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) is a 5-lipoxygenase product that acts via the selective OXE receptor, which is present in many species, but not rodents. We previously reported that the indole 230 is a potent human OXE receptor antagonist. The objective of the present study was to determine whether the monkey would be a suitable animal model to investigate its pharmaceutical potential. We found that monkey leukocytes synthesize and respond to 5-oxo-ETE and that 230 is a potent antagonist of the OXE receptor in monkey eosinophils. Pharmacokinetic studies revealed that 230 appears rapidly in the blood following oral administration. Using chemically synthesized standards, we identified the major microsomal and plasma metabolites of 230 as products of ω2-hydroxylation of the alkyl side chain. These studies demonstrate that the monkey is a promising animal model to investigate the drug potential of OXE receptor antagonists.
authors: Meakins-Christie Laboratories, Centre for Translational Biology, McGill University Health Centre , 1001 Decarie Boulevard, Montreal, Quebec H4A 3J1, Canada.
authors: Chantal
authors: C
authors: Cossette
authors: Claude Pepper Institute and Department of Chemistry, Florida Institute of Technology , 150 West University Boulevard, Melbourne, Florida 32901-6982, United States.
authors: Shishir
authors: S
authors: Chourey
authors: Claude Pepper Institute and Department of Chemistry, Florida Institute of Technology , 150 West University Boulevard, Melbourne, Florida 32901-6982, United States.
authors: Qiuji
authors: Q
authors: Ye
authors: Claude Pepper Institute and Department of Chemistry, Florida Institute of Technology , 150 West University Boulevard, Melbourne, Florida 32901-6982, United States.
authors: Chintam
authors: C
authors: Nagendra Reddy
authors: Claude Pepper Institute and Department of Chemistry, Florida Institute of Technology , 150 West University Boulevard, Melbourne, Florida 32901-6982, United States.
authors: Vivek
authors: V
authors: Gore
authors: Meakins-Christie Laboratories, Centre for Translational Biology, McGill University Health Centre , 1001 Decarie Boulevard, Montreal, Quebec H4A 3J1, Canada.
authors: Sylvie
authors: S
authors: Gravel
authors: Department of Chemistry and Biochemistry and PERFORM Centre, Concordia University , 7141 Sherbrooke Street West, Montréal, Quebec H4B 1R6, Canada.
authors: Irina
authors: I
authors: Slobodchikova
authors: Department of Chemistry and Biochemistry and PERFORM Centre, Concordia University , 7141 Sherbrooke Street West, Montréal, Quebec H4B 1R6, Canada.
authors: Dajana
authors: D
authors: Vuckovic
authors: Claude Pepper Institute and Department of Chemistry, Florida Institute of Technology , 150 West University Boulevard, Melbourne, Florida 32901-6982, United States.
authors: Joshua
authors: J
authors: Rokach
authors: Meakins-Christie Laboratories, Centre for Translational Biology, McGill University Health Centre , 1001 Decarie Boulevard, Montreal, Quebec H4A 3J1, Canada.
authors: William S
authors: WS
authors: Powell
mesh_terms: D000818:Animals; D001095:Arachidonic Acids / Q000737:chemistry / Q000378:metabolism* / Q000493:pharmacokinetics / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006098:Granulocytes / Q000166:cytology / Q000187:drug effects*; D000882:Haplorhini; D015394:Molecular Structure; D018055:Receptors, Eicosanoid / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship
chemical_list: D001095:Arachidonic Acids; D018055:Receptors, Eicosanoid; C080828:5-oxo-6,8,11,14-eicosatetraenoic acid